You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (9)

Journals (0)

1-9 of 9 results for hypomethylating agents failure

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Management of myelodysplastic syndromes after failure of response to hypomethylating agents

Open access

Review article

First published 2019

Management of myelodysplastic syndromes after failure of response to hypomethylating agents

Angela Gil-Perez, Guillermo Montalban-Bravo

Therapeutic Advances in Hematology

Select article: Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failure

Free access

Research article

First published 2014-4

Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failure

Hady Ghanem, Guillermo Garcia-Manero, Stefan Faderl [...]

Therapeutic Advances in Hematology

Select article: The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?

Open access

Review article

First published 2022

The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?

Anson Snow, Joshua F. Zeidner

Therapeutic Advances in Hematology

Select article: Treatment options for lower-risk myelodysplastic syndromes. Where are we now?

Open access

Review article

First published 2021

Treatment options for lower-risk myelodysplastic syndromes. Where are we now?

Virginia O. Volpe, Rami S. Komrokji

Therapeutic Advances in Hematology

Select article: Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes

Free access

Review article

First published 2017-1

Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes

Shyamala C. Navada, Lewis R. Silverman

Therapeutic Advances in Hematology

Select article: Targeting the Myeloid Lineages and the Immune Microenvironment in Myelodysplastic Syndromes: Novel and Evolving Therapeutic Strategies

Retricted access

Review article

First published 2022-4

Targeting the Myeloid Lineages and the Immune Microenvironment in Myelodysplastic Syndromes: Novel and Evolving Therapeutic Strategies

Clement Chung

Annals of Pharmacotherapy

Select article: Marginal zone lymphoma: old,new,targeted,and epigenetic therapies

Free access

Review article

First published 2012-10

Marginal zone lymphoma: old,new,targeted,and epigenetic therapies

Monika Joshi, Hassan Sheikh, Kamal Abbi [...]

Therapeutic Advances in Hematology

Select article: Effect of 5-Azacytidine: Evidence for Alteration of the Multipotent Ability of Mesenchymal Stem Cells

Retricted access

Research article

First published 2011-07

Effect of 5-Azacytidine: Evidence for Alteration of the Multipotent Ability of Mesenchymal Stem Cells

Ana-Maria Rosca, Alexandrina Burlacu

Stem Cells and Development

Select article: Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia

Open access

Review article

First published 2022

Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia

Curtis A. Lachowiez, Himachandana Atluri, Courtney D. DiNardo

Therapeutic Advances in Hematology

1
10 / page

Article type

Publication date

Subjects

Access